Global Enteral Stents Market Size By Type (Esophageal Stents, Gastroduodenal Stents), By Application (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Enteral Stents Market was valued at USD 405.6 million in 2023 and is projected to reach USD 722.4 million by 2031, growing at a CAGR of 7.4% during the forecast period of 2023–2031. Enteral stents are medical devices used to alleviate obstructions in the gastrointestinal tract caused by conditions such as cancer, strictures, or other abnormalities. The market is being driven by the increasing prevalence of gastrointestinal cancers, rising demand for minimally invasive procedures, and continuous advancements in stent technologies that enhance patient outcomes and procedural ease.

Drivers

1. Increasing Prevalence of Gastrointestinal Disorders:

The global rise in colorectal, esophageal, and gastric cancers is contributing significantly to the demand for enteral stents. These stents provide immediate relief from obstructions, thereby improving quality of life for patients.

2. Surge in Minimally Invasive Surgeries:

The growing preference for non-surgical, endoscopic interventions over traditional surgery is accelerating the adoption of enteral stents. These devices reduce hospital stays, complications, and recovery time.

3. Technological Innovations:

The development of drug-eluting and biodegradable stents, along with better delivery systems, is enhancing the clinical effectiveness and safety profile of enteral stents, spurring wider adoption.

Restraints

1. High Costs of Advanced Stents:

Innovative stents often come with higher costs, limiting their affordability in low- and middle-income countries. Reimbursement challenges in some regions further hinder market penetration.

2. Risk of Complications:

Though less invasive, enteral stents are associated with potential risks such as stent migration, perforation, or re-obstruction, which can affect long-term efficacy and patient safety.

Opportunity

1. Growing Geriatric Population:

With aging populations worldwide, the incidence of age-related gastrointestinal conditions is rising. This demographic shift presents a significant opportunity for market expansion.

2. Expansion in Emerging Markets:

Rapid improvements in healthcare infrastructure and increasing awareness in countries such as India, Brazil, and China are paving the way for the adoption of advanced medical devices like enteral stents.

Market by System Type Insights

By system type, Self-Expandable Metal Stents (SEMS) dominated the market in 2023. These stents are favored for their flexibility, conformability, and ability to provide prolonged patency. Innovations in SEMS designs, such as anti-migration features and drug-eluting capabilities, are further boosting their popularity. Meanwhile, Plastic Stents continue to be used for short-term relief but are gradually being replaced due to lower performance and higher complication rates.

Market by End-use Insights

The Hospitals segment emerged as the largest end-use category in 2023, accounting for over 50% of the global revenue. Hospitals are the primary centers for endoscopic procedures and stent placements due to the availability of specialized equipment and expertise. Ambulatory Surgical Centers (ASCs) are expected to register the fastest growth during the forecast period owing to the rise in outpatient endoscopy and cost-effective treatment alternatives.

Market by Regional Insights

North America led the global enteral stents market in 2023, driven by high prevalence of gastrointestinal cancers, advanced healthcare infrastructure, and early adoption of new technologies. Asia-Pacific is anticipated to be the fastest-growing region, fueled by a large patient base, improving healthcare systems, and rising awareness of minimally invasive treatments.

Competitive Scenario

Key players in the Global Enteral Stents Market include Boston Scientific Corporation, Cook Medical, Olympus Corporation, Taewoong Medical Co., Ltd., ELLA-CS, Medtronic plc, Becton, Dickinson and Company, CONMED Corporation, Micro-Tech (Nanjing) Co., Ltd., and M.I. Tech. These companies are focusing on R&D, product innovation, and strategic collaborations to enhance their market position.

Recent Developments:

In 2023, Boston Scientific introduced a next-generation enteral stent featuring anti-migration technology and improved delivery system.

In 2024, Taewoong Medical launched a drug-eluting SEMS aimed at reducing post-placement complications in palliative care.

In 2025, Olympus Corporation announced a partnership with leading gastroenterology clinics to pilot AI-assisted stent placement systems.

Scope of Work – Global Enteral Stents Market

Report Metric Details

Market Size (2023) USD 405.6 million

Projected Market Size (2031) USD 722.4 million

CAGR (2023–2031) 7.4%

Key Segments System Type (SEMS, Plastic Stents), End-use (Hospitals, ASCs)

Growth Drivers Increasing cancer cases, rise in minimally invasive surgeries, stent innovations

Opportunities Geriatric demographics, emerging market expansion

Key Market Developments

2023: Boston Scientific launched anti-m